Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation

Human Gene Therapy

Volumn 11, Issue 1, 2000, Pages 205-211

  Engstrand, Thomas ^a,b   Daluiski, Aaron ^a   Bahamonde, Matthew E ^a   Melhus, Håkan ^b   Lyons, Karen M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2;

ANIMAL CELL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; OSSIFICATION; PROTEIN PURIFICATION; QUADRICEPS FEMORIS MUSCLE; STEM CELL;

ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; DNA PRIMERS; GENETIC VECTORS; HUMANS; MALE; MICE; RECOMBINANT PROTEINS; RETROVIRIDAE; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033962919     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050016274     Document Type: Article

References (29)

1. Aspenberg, P., and Turek, T. (1996). BMP-2 for intramuscular bone induction: Effect in squirrel monkeys is dependent on implantation site. Acta Orthoped. Scand. 67, 3-6.
2. Bostrom, M.P.G., Lane, J.M., Berberian, W.S., Missri, A.E.A., Tomin, E., Weiland, A., Doty, S.B., Glaser, D., and Rosen, V. (1995). Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J. Orthoped. Res. 13, 357-367.
3. Breitbart, A.S., Grande, D.A., Mason, J.M., Barcia, M., James, T., and Grant, R.T. (1999). Gene-enhanced tissue engineering: Application for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann. Plastic Surg. 42, 488-495.
4. Bruder, S.P., Jaiswal, N., Ricalton, N.S., Mosca, J.S., Kraus, K.H., and Kadiyala, S. (1998). Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin. Orthoped. 355 (Suppl.), S247-S256.
5. Fang, J., Zhu, Y.Y., Smiley, E., Bonadio, J., Rouleau, J.P., Goldstein, S.A., McCauley, L.K., Davidson, B.L., and Roessler, B.J. (1996). Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. U.S.A. 93, 5753-5758.
6. Freedman, V.H., and Shin, S.I. (1974). Cellular tumorigenicity in nude mice: Correlation with cell growth in semi-solid medium. Cell 3, 355-359.
7. Fromigue, O., Marie, P.J., and Lomri, A. (1998). Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J. Cell Biochem. 68, 411-426.
8. Goldstein, S., and Bonadio, J. (1998). Potential role for direct gene transfer in the enhancement of fracture healing. Clin. Othoped. 355(Suppl.) S154-S162.
9. Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., Koo, W.W., Gordon, P.L., Neel, M., Sussman, M., Orchard, P., Marx, J.C., Yeritz, R.E., and Brenner, M.K. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Med. 5, 309-313.
10. Kazhdan, I., Rickard, D., and Leboy, P.S. (1997). HLH transcription factor activity in osteogenic cells. J. Cell Biochem. 65, 1-10.
11. Kim, K.J., Itoh, T., and Kotake, S. (1997). Effects of recombinant human bone morphogenetic protein-2 on human bone marrow stromal cells cultured with various biomaterials. J. Biomed. Mater. Res. 35, 279-285.
12. Kosimoto, K., Bessho, K., Fujimura, K., Akioka, J., Ogawa, Y., and Iizuka, T. (1997). Comparison of ectopic osteoinduction in vivo by recombinant human BMP-2 and recombinant Xenopus BMP-4/7 heterodimer. Biochem. Biophys. Res. Commun. 239, 575-579.
13. Lecanda, F., Avioloi, L.V., and Cheng, S.L. (1997). Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J. Cell Biochem. 67, 386-396.
14. Lieberman, J.R., Le, L.Q., Wu, L., Finerman, G.R., Berk, A., Witte, O.N., and Stevenson, S. (1998). Regional gene therapy with a BMP-2 producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J. Orthoped. Res. 16, 330-339.
15. Lieberman, J.R., Daluiski, A., Stevenson, S., Wu, L., McAllister, P., Lee, Y.P., Kabo, J.M., Finerman, G.A., Berk, A.J., and Witte, O.N. (1999). The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81, 905-917.
16. Mulligan, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
17. Musgrave, D.S., Bosch, P., Ghivizzani, S., Robbins, P.D., Evans, C.H., and Huard, J. (1999). Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24, 541-547.
18. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
19. Qin, L., Ding, Y., and Bromberg, J.S. (1996). Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum. Gene Ther. 7, 1981-1988.
20. Shin, S.I., Freedman, V.H., Risser, R., and Pollack, R. (1975). Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. U.S.A. 72, 4435-4439.
21. Stockley, T.L., and Chang, P.L. (1997a). Non-autologous transplantation with immuno-isolation in large animals - a review. Ann. N.Y. Acad. Sci. 831, 408-426.
22. Stockley, T.L., and Chang, P.L. (1997b). Gene therapy for diabetes: Strategies for beta-cell modification and replacement. Diab. Metab. Rev. 13, 209-246.
23. Suthanthiran, M., and Strom, T.B. (1995). Immunobiology and immunopharmacology of organallograft rejection. J. Clin. Immunol. 15, 161-171.
24. Temin, H.M. (1990). Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum. Gene Ther. 1, 111-123.
25. Thies, R.S., Baundy, M., Ashton, B.A., Kurtzberg, L., Wozney, J.M., and Rosen, V. (1992). Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130, 1318-1324.
26. Wagner, J.A., and Gardner, P. (1997). Toward cystic fibrosis gene therapy. Annu. Rev. Med. 48, 203-216.
27. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., Israel, D.I., Hewick, R.M., Kerns, K.M., Lapan, P., Luxenberg, D.P., McQuaid, D., Moutsatsos, I., Nove, J., and Wozney, J.M. (1990). Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U.S.A. 87, 2220-2224.
28. Wozney, J.H., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. (1988). Novel regulators of bone formation: Molecular clones and activities. Science 242, 1528-1533.
29. Zimmerman, L.B., De Jesus-Escobar, J.M., and Harland, R.M. (1996). The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599-606.